TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
Got $1,000? Buy These 3 Canadian Value Stocks for Superior Returns

Cannabis Stocks
Why Cannabis Stocks Jumped on Wednesday

Cannabis Stocks
TSX Today: What to Watch for in Stocks on Thursday, February 10

Cannabis Stocks
Down Over 10% for This Year: Should You Buy These 2 Cannabis Stocks?

Cannabis Stocks
Canopy Growth Stock Jumps 10% on Earnings

Cannabis Stocks
Cannabis Sector Paid $15 Billion in Taxes, But Still No Growth in Weed Stocks

Cannabis Stocks
Why Canopy Growth Stock Grew 10% on Monday

Stocks for Beginners
3 Cheap TSX Stocks Under $10 to Buy for a 2022 Recovery

Cannabis Stocks
Why Did Cannabis Stocks Go up in Smoke on Monday?

Cannabis Stocks
Frustration, Not Profits: 3 Must-Avoid Weed Stocks in 2022

Cannabis Stocks
Is Canopy Growth (TSX:WEED) the Best Growth Stock to Buy in 2022?
